文献速递基层心理健康慢病管理

提供者视角:阿片类药物与精神健康共病协作照护的质性研究

Provider experiences delivering collaborative care for co-occurring opioid and mental health disorders: a qualitative study.
PubMed 文献 · Fam Pract · 2025-01-01

本研究基于两项卫生系统中随机对照试验的半结构化访谈,探讨初级保健提供者、照护协调员、行为健康提供者、诊所管理员及精神科顾问对协作照护模式的经验。参与者认为共病患者的污名化、症状严重度和治疗障碍均高于单纯阿片类药物使用障碍患者,但认可协作照护对患者及诊所的积极影响,并提出未来实施所需的系统与政策建议。

要点

  • 共病患者比单纯阿片类药物使用障碍患者面临更高污名、更重症状和更多治疗障碍。
  • 提供者认可协作照护对共病患者、诊所及照护者的积极影响。
  • 提供者支持未来使用协作照护,但强调需系统与政策层面的支持。

核心结论

  • 尽管治疗共病患者比单纯阿片类药物使用障碍患者更具挑战,提供者仍认为协作照护对此复杂人群有益,并支持未来推广。

研究设计与样本

  • 作为两项卫生系统中随机对照试验的一部分,对参与协作照护的提供者进行半结构化访谈,采用内容分析识别主题与亚主题。

主要发现

  • 参与者感知到单纯阿片类药物使用障碍患者与共病患者之间存在差异,如污名更高、症状更重、治疗障碍更多。
  • 参与者感知到协作照护干预对共病患者及照护他们的诊所和提供者具有积极影响。
  • 参与者识别出未来实施协作照护需考虑的要素,并提出系统与政策建议。

临床怎么用

  • 在基层为阿片类药物使用障碍合并抑郁和/或创伤后应激障碍患者提供协作照护时,需关注更高污名、更重症状和更多治疗障碍。
  • 推广协作照护需同步考虑系统与政策层面的支持措施。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Opioids are the primary contributor to overdose death in the USA and represent a major public health crisis despite the availability of highly effective evidence-based treatments. A co-occurring mental health disorder further complicates efforts to utilize effective treatments and leads to poorer outcomes. Collaborative care has shown promise in improving care for those with substance use disorders and those with mental health disorders. This study explores the experiences of providers participating in a randomized controlled trial of collaborative care for both opioid use disorder (OUD) and co-occurring depression and/or posttraumatic stress disorder (COD). METHODS: Semi-structured interviews were conducted with healthcare providers of collaborative care as part of a randomized controlled trial at two health systems. Interviewed participants included primary care providers, care coordinators, behavioral health providers, clinic administrators, and psychiatric consultants. Data was analyzed with content analysis to identify common themes and subthemes among experiences. FINDINGS: Participants perceived differences between patients diagnosed with only OUD and those with COD, such as heightened stigma, greater symptom severity, and more barriers to treatment. They perceived the positive impacts of the collaborative care intervention for patients with COD and the clinics and providers caring for this population, and identified considerations for future implementation efforts. CONCLUSIONS: Although participants noted challenges in treating patients with COD compared to those with only OUD, they also perceived the benefits of using collaborative care in this complex population. Participants supported using collaborative care in the future, but noted important systems and policy suggestions needed for successful implementation.

来源:Fam Pract,查看原文。版权归原作者所有。

引用

  1. Christensen J, Hindmarch G, Cueto L, et al. Provider experiences delivering collaborative care for co-occurring opioid and mental health disorders: a qualitative study. Fam Pract. 2025. PMID: 40105122. doi:10.1093/fampra/cmaf007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。